oseltamivir has been researched along with Disease, Pulmonary in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azimi, PH; Boom, JA; Campbell, AP; Englund, JA; Haddadin, Z; Halasa, NB; Hamdan, L; Harrison, CJ; Klein, EJ; McNeal, M; Munoz, F; Patel, M; Probst, V; Rahman, H; Sahni, LC; Selvarangan, R; Singer, MN; Spieker, AJ; Staat, MA; Stewart, LS; Szilagyi, PG; Vandekar, S; Weinberg, GA; Williams, JV | 1 |
| de Briel, D; Heller, R; Martin, A; Martinot, M; Mohseni-Zadeh, M; Mothes, A; Sagot, E; Souply, L | 1 |
| Blumentals, WA; Piedra, PA; Schulman, KL | 1 |
| Kobayashi, N; Koizumi, T; Kubo, K; Tsushima, K; Urushihata, K; Ushiki, A; Yokoyama, T | 1 |
| Bakal, I; Fox, BD; Kramer, MR; Raviv, Y; Rozengarten, D; Rusanov, V | 1 |
| Calitri, C; Cuozzo, M; Gabiano, C; Garazzino, S; Pinon, M; Scolfaro, C; Tovo, PA; Zoppo, M | 1 |
| Dubielzig, RR; Hatta, M; Hatta, Y; Hershberger, K; Katze, MG; Kawaoka, Y; Proll, SC; Shinya, K; Suresh, M | 1 |
| Hurst, BL; Smee, DF; Wong, MH | 1 |
| Ahn, JH; Choi, HJ; Kwak, IS; Lee, SB; Lee, YJ; Rhee, H; Seong, EY; Song, SH | 1 |
| Bailey, KW; Barnard, DL; Huffman, JH; Kim, CU; Morrison, A; Sidwell, RW; Syndergaard, T; Wong, MH | 1 |
10 other study(ies) available for oseltamivir and Disease, Pulmonary
| Article | Year |
|---|---|
Influenza clinical testing and oseltamivir treatment in hospitalized children with acute respiratory illness, 2015-2016.
Topics: Antiviral Agents; Child; Child, Hospitalized; Hospitalization; Humans; Influenza, Human; Lung Diseases; Oseltamivir | 2022 |
Contribution of systematic RT-PCR screening for influenza during the epidemic season.
Topics: Adult; Aged; Anti-Bacterial Agents; Antiviral Agents; Cross Infection; Delayed Diagnosis; Diagnosis, Differential; Disease Outbreaks; Emergency Service, Hospital; Female; Fever; France; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza B virus; Influenza, Human; Lung Diseases; Male; Middle Aged; Oseltamivir; Patients' Rooms; Reagent Kits, Diagnostic; Real-Time Polymerase Chain Reaction; Seasons; Sensitivity and Specificity | 2014 |
Effects of oseltamivir on influenza-related complications in children with chronic medical conditions.
Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Chronic Disease; Female; Hospitalization; Humans; Infant; Influenza, Human; Lung Diseases; Male; Oseltamivir; Otitis Media; Proportional Hazards Models; Retrospective Studies | 2009 |
Acute lung injury with alveolar hemorrhage due to a novel swine-origin influenza A (H1N1) virus.
Topics: Acute Lung Injury; Adult; Antiviral Agents; Female; Glycine; Hemorrhage; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Lung Diseases; Oseltamivir; Sulfonamides; Treatment Outcome | 2010 |
Pandemic influenza (H1N1): impact on lung transplant recipients and candidates.
Topics: Adolescent; Adult; Antiviral Agents; Child; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Israel; Lung Diseases; Lung Transplantation; Male; Middle Aged; Oseltamivir; Pandemics; Patient Selection | 2010 |
Clinical features of hospitalised children with 2009 H1N1 influenza virus infection.
Topics: Adolescent; Antiviral Agents; Child; Child, Hospitalized; Child, Preschool; Cough; Female; Fever; Humans; Infant; Influenza A Virus, H1N1 Subtype; Influenza, Human; Italy; Lung Diseases; Male; Medical Records; Nervous System Diseases; Oseltamivir; Treatment Outcome | 2010 |
Viral replication rate regulates clinical outcome and CD8 T cell responses during highly pathogenic H5N1 influenza virus infection in mice.
Topics: Animals; CD8 Antigens; CD8-Positive T-Lymphocytes; Cells, Cultured; Dogs; Humans; Influenza A Virus, H5N1 Subtype; Influenza, Human; Lung Diseases; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Orthomyxoviridae Infections; Oseltamivir; Prognosis; Virus Replication | 2010 |
Effects of TheraMax on influenza virus infections in cell culture and in mice.
Topics: Administration, Intranasal; Animals; Antiviral Agents; Camellia sinensis; Cell Line; Dogs; Drug Evaluation, Preclinical; Hemorrhage; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza B virus; Lung; Lung Diseases; Mice; Mice, Inbred BALB C; Nasal Cavity; Orthomyxoviridae Infections; Oseltamivir; Plant Extracts; Sambucus; Toxicity Tests; Weight Loss | 2011 |
Pandemic H1N1 influenza A viral infection complicated by atypical hemolytic uremic syndrome and diffuse alveolar hemorrhage.
Topics: Adult; Antiviral Agents; Atypical Hemolytic Uremic Syndrome; Hemodiafiltration; Hemolytic-Uremic Syndrome; Hemorrhage; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Lung Diseases; Male; Oseltamivir; Pandemics; Plasma Exchange; Pulse Therapy, Drug; Republic of Korea; Steroids; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor.
Topics: Acetamides; Administration, Intranasal; Administration, Oral; Amines; Animals; Antiviral Agents; Cell Line; Disease Models, Animal; Dogs; Enzyme Inhibitors; Female; Guanidines; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Lung Diseases; Mice; Mice, Inbred BALB C; Molecular Structure; Neuraminidase; Oseltamivir; Pyrans; Ribavirin; Sialic Acids; Zanamivir | 1998 |